This is an official Canadian Stroke Consortium (CSC) - StrokeFM Podcast episode: Neuroprotection and stroke care What does the future hold?  Where are we coming from and where are we going?  These and other exciting topics of discussion in conversation with Dr. Michael Hill (Calgary Stroke Program) as we chat about ESCAPE NA1 and ESCAPE NEXT. ESCAPE-NEXT is a multi-centre, randomized, double-blinded, placebo-controlled, parallel Group, single-dose trial designed to determine the efficacy and safety of Nerinetide in participants with acute ischemic stroke undergoing endovascular thrombectomy excluding thrombolysis. This is an official CSC Podcast episode (Season 2, Episode 8). As usual, see our Disclaimer about this educational podcast.  Please follow us on Twitter: @strokefm Subscribe to the Podcast and give us 5 stars! Apple PodCast Spotify PodCast